Fusion Pharmaceuticals Inc (FUSN)
21.42
0.00 (0.00%)
USD |
NASDAQ |
May 07, 16:00
21.42
0.00 (0.00%)
After-Hours: 20:00
Fusion Pharmaceuticals Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
September 30, 2023 | 2.208M |
June 30, 2023 | 0.368M |
March 31, 2023 | 0.904M |
December 31, 2022 | 1.461M |
Date | Value |
---|---|
September 30, 2022 | 1.915M |
June 30, 2022 | 2.074M |
March 31, 2022 | 2.025M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.368M
Minimum
Jun 2023
2.208M
Maximum
Sep 2023
1.565M
Average
1.915M
Median
Sep 2022
Revenue (TTM) Benchmarks
AstraZeneca PLC | 47.61B |
Landos Biopharma Inc | -- |
Perspective Therapeutics Inc | 0.00 |
Acasti Pharma Inc | -- |
Aurinia Pharmaceuticals Inc | 175.51M |